摘要
Background: Molecular connectivity, assessed through interindividual correlations of PET-derived measures, may capture the network-level organization of neurotransmitter systems. However, its anatomical basis remains unclear. We tested whether striatal subregions sharing similar cortical structural-connectivity fingerprints exhibit stronger molecular connectivity of dopamine-synthesis capacity.
Methods: Twenty healthy participants underwent [¹⁸F]FDOPA PET and diffusion MRI twice. Session-averaged Patlak Kᵢ (cerebellar reference) was extracted for ten Brainnetome striatal subregions. Cortical structural-connectivity fingerprints comprised group-mean probabilistic-tractography profiles to 105 ipsilateral cortical regions. Striatal molecular connectivity was quantified using age- and sex-adjusted between-subject Kᵢ correlations. Across 20 within-hemisphere subregion pairs, molecular connectivity was related to cortical fingerprint similarity, controlling for centroid distance and Kᵢ test-retest reliability. Inference used exact within-hemisphere permutations and participant-bootstrap confidence intervals. Additional sensitivity analyses assessed robustness.
Results: Striatal molecular connectivity increased with cortical fingerprint similarity (partial Spearman ρ=0.78, 95% CI 0.54-0.94, p<0.001). Associations were observed in both hemispheres (left: ρ=0.93, p=0.008; right: ρ=0.64, p=0.033) and separately in both sessions (ρ=0.52 and 0.67; p=0.032 and 0.004). Structural fingerprint similarity was highly reproducible (ρ=0.99). Importantly, the association persisted after adjustment for whole-striatum Kᵢ (ρ=0.47, p=0.029) and remained robust to ventral-dorsal adjustment, inclusion of cross-hemisphere pairs, and leave-one-subregion-out analyses.
Conclusions: Dopamine-synthesis molecular connectivity reflects corticostriatal anatomical organization beyond global variation in striatal Kᵢ. These findings provide an anatomical basis for interpreting molecular connectivity of a specific neurotransmitter system and establish a multimodal framework for investigating circuit-level dopaminergic alterations in Parkinsonism, psychosis, and related disorders.
